Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$7.5 - $15.31 $135,442 - $276,483
-18,059 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$7.29 - $13.01 $131,650 - $234,947
18,059 New
18,059 $235,000
Q3 2018

Oct 16, 2018

SELL
$11.93 - $14.76 $274,366 - $339,450
-22,998 Closed
0 $0
Q2 2018

Jul 17, 2018

BUY
$11.39 - $16.26 $261,947 - $373,947
22,998 New
22,998 $271,000

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.